The Nanosonics Ltd (ASX:NAN) share price has fallen heavily from its 52-week high. Is this a buying opportunity for investors?
The post Is the Nanosonics (ASX:NAN) share price a buy? appeared first on Motley Fool Australia. –
The Nanosonics Ltd (ASX: NAN) share price is currently trading approximately 25% lower than its 52-week high.
Is this a buying opportunity for investors? I thought I would take a closer look to find out:
Nanosonics’ trophon EPR product is a best in class disinfection system for ultrasound probes. Over the last few years, the company has been growing its installed base at a consistently strong rate.
So much so, at the end of FY 2020 it had grown its installed base by 13% over the 12 months to 23,720 units. This is positive for two reasons. The first is the revenue it generates from unit sales, the second is the sales it then generates from the consumables it requires.
This means that as its installed base grows, so too do the recurring revenues from consumables. For example, full year consumables and service revenue was up 36% to $70.1 million in FY 2020. This now accounts for approximately 70% of its total revenue.
Another reason to be positive is the increased awareness of infection prevention because of the pandemic.
Management commented: “The COVID-19 pandemic has reinforced the importance of infection prevention and given increased prominence to this important topic, not just amongst the medical community but in all communities. The Company considers that this can only be positive for the longer term fundamentals of the business.”
For several years now, Nanosonics has been promising to release new products targeting other unmet needs with similar addressable markets.
Given its great reputation, distribution channels, and expertise, the market has been very excited about these new products and have been using them to justify the premium its shares trade at. At present, Nanosonics’ shares are changing hands for 127x FY 2019 (pre-COVID) earnings.
However, these new products just keep getting pushed further and further back.
After first promising a new product back in FY 2017, according to Goldman Sachs, the latest estimate is now FY 2022.
Management explained: “Commercialisation of the new technology is no longer expected to be in FY21 but will likely be in FY22, with the ultimate launch timing continuing to be dependent on the necessary technical milestones being met as well as the timing of individual market regulatory approvals.”
My concern is that if the market starts to doubt this latest estimate, it could begin to take these products out of the equation, causing a significant de-rating of its shares.
While the delays are disappointing, I think it could still be worth buying and holding Nanosonics’ shares for the long term.
However, due to the premium its shares trade at and management’s habit of missing deadlines, I would suggest investors restrict an investment to just a small part of a balanced portfolio.
After which, when things become more certain, investors could consider increasing their holding.
Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
- ASX 200 Weekly Wrap: Budget, US election sparks 5% surge in ASX shares
- These were the worst performing shares on the ASX 200 last week
- Are these 2 ASX 200 healthcare shares a buy yet?
- ASX technology stocks to buy during this global tech sell-off
- Is the Nanosonics (ASX:NAN) share price in the buy zone?
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nanosonics Limited. The Motley Fool Australia has recommended Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.